PrairieView Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37K | Hold |
800
| – | – | ﹤0.01% | 206 |
|
|
2025
Q1 | $48K | Hold |
800
| – | – | 0.01% | 192 |
|
|
2024
Q4 | $45K | Hold |
800
| – | – | ﹤0.01% | 203 |
|
|
2024
Q3 | $41K | Sell |
800
-495
| -38% | -$25.4K | ﹤0.01% | 209 |
|
|
2024
Q2 | $53K | Buy |
1,295
+16
| +1% | +$655 | 0.01% | 198 |
|
|
2024
Q1 | $70K | Buy |
1,279
+6
| +0.5% | +$328 | 0.01% | 162 |
|
|
2023
Q4 | $65K | Buy |
1,273
+5
| +0.4% | +$255 | 0.01% | 161 |
|
|
2023
Q3 | $73K | Buy |
1,268
+4
| +0.3% | +$230 | 0.01% | 151 |
|
|
2023
Q2 | $80K | Sell |
1,264
-26
| -2% | -$1.65K | 0.01% | 166 |
|
|
2023
Q1 | $89K | Buy |
1,290
+34
| +3% | +$2.35K | 0.01% | 144 |
|
|
2022
Q4 | $90K | Buy |
1,256
+803
| +177% | +$57.5K | 0.01% | 145 |
|
|
2022
Q3 | $32K | Buy |
453
+3
| +0.7% | +$212 | 0.01% | 212 |
|
|
2022
Q2 | $35K | Hold |
450
| – | – | 0.01% | 223 |
|
|
2022
Q1 | $33K | Hold |
450
| – | – | ﹤0.01% | 237 |
|
|
2021
Q4 | $28K | Hold |
450
| – | – | ﹤0.01% | 262 |
|
|
2021
Q3 | $27K | Hold |
450
| – | – | ﹤0.01% | 212 |
|
|
2021
Q2 | $30K | Buy |
450
+246
| +121% | +$16.4K | ﹤0.01% | 198 |
|
|
2021
Q1 | $13K | Buy |
+204
| New | +$13K | ﹤0.01% | 249 |
|